Eventide Healthcare & Life Sciences Fund is a registered fund series of MUTUAL FUND SERIES TRUST (series S000039514). Net assets $1.6B as of 2026-03-31.
Showing 15 of 92 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Guardant Health Inc | — | $64.7M | 407.46% |
| Mirum Pharmaceuticals Inc. | — | $63.8M | 401.99% |
| Insmed Inc | — | $60.0M | 378.19% |
| US BANK MMDA | — | $58.0M | 365.13% |
| BeLite Bio Inc | — | $52.4M | 330.03% |
| Kymera Therapeutics Inc | — | $52.1M | 328.42% |
| Vaxcyte Inc | — | $48.1M | 302.89% |
| Apogee Therapeutics Inc. | — | $46.9M | 295.53% |
| Ionis Pharmaceuticals, Inc. | — | $43.2M | 271.96% |
| Argenx SE | — | $35.9M | 226.27% |
| Abivax SA | — | $35.7M | 224.66% |
| Scholar Rock Holding Corp. | — | $35.3M | 222.58% |
| Celldex Therapeutics Inc. | — | $32.9M | 207.19% |
| iRhythm Holdings Inc. | — | $32.8M | 206.47% |
| Bridgebio Pharma Inc | — | $32.5M | 204.47% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $1.6B |
| 2025-12-31 | $1.7B |
| 2025-09-30 | $1.3B |
| 2025-06-30 | $1.1B |
| 2025-03-31 | $1.1B |
| 2024-12-31 | $1.3B |
| 2024-09-30 | $1.5B |
| 2024-06-30 | $1.4B |